China Biologic Products Holdings OverviewChina Biologic Products Holdings Research & Development
Research & Development expenses for CBPO.
Quarterly R&D Expenses
$2.84M
↓ 33.73% YoY
As of Dec 31, 2020
Annual R&D Expenses (TTM)
$8.58M
↓ 26.85% YoY
Trailing 12 months ending Dec 31, 2020